Description:

CALGB 90601: On-Study Form NCT00942331 Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=653FC86F-74B9-C88B-E040-BB89AD432982

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=653FC86F-74B9-C88B-E040-BB89AD432982

Keywords:
Versions (5) ▾
  1. 8/26/12
  2. 8/11/14
  3. 1/9/15
  4. 6/16/15
  5. 7/30/15
Uploaded on:

July 30, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

On-Study Advanced Urinary Tract Cancer CALGB 90601 NCT00942331

All Patients

  1. StudyEvent: CALGB 90601: On-Study Form
    1. All Patients
Header module
Are data amended
Initial Diagnosis
T Stage, Clinical
N Stage, Clinical
M Stage, Clinical
Bladder
Renal pelvis
Ureter
Urethra
Was cystectomy performed
T Stage, Pathologic
N Stage, Pathologic
M Stage, Pathologic
Was nephrectomy and/or ureterectomy performed
Was an ureterectomy performed
Histologic Grade Bladder Tumor
Histologic Grade (OR)
Prostate
Uterus
Vagina
Pelvic wall
Abdominal wall
Other
Bladder Malignant Neoplasm
Regional Lymph Nodes
Distant metastases present?
Specify sites
Baseline performance status
Smoking History
Laboratory Values
10^3/mcL
1000/uL
mg/dL
mg/dl
U/L
U/L
U/L
U/L
ml/min
Urinalysis
Urine Protein (Mark one with an X.)
g/24 hours
Prior Treatment - Systemic Regimens
Prior Treatment
Regimen type
Ccrr Module For Calgb: 90202 On-study